Central precocious puberty in a boy with pseudohypoparathyroidism type ia due to a novel GNAS mutation

Ryosuke Kagami; Takeshi Sato; Tomohiro Ishii; Eriko Araki; Yukio Yamashita; Hironori Shibata; Jun Ishihara; Tomonobu Hasegawa

doi:10.1297/cpe.29.89

Central precocious puberty in a boy with pseudohypoparathyroidism type ia due to a novel GNAS mutation

Ryosuke Kagami, Takeshi Sato, Tomohiro Ishii, Eriko Araki, Yukio Yamashita, Hironori Shibata, Jun Ishihara, Tomonobu Hasegawa

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	89-90
Number of pages	2
Journal	clinical pediatric endocrinology
Volume	29
Issue number	2
DOIs	https://doi.org/10.1297/cpe.29.89
Publication status	Published - 2020

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Endocrinology, Diabetes and Metabolism
Endocrinology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1297/cpe.29.89

Cite this

@article{d8ee9ba7fddd4136a7705645404d7397,

title = "Central precocious puberty in a boy with pseudohypoparathyroidism type ia due to a novel GNAS mutation",

author = "Ryosuke Kagami and Takeshi Sato and Tomohiro Ishii and Eriko Araki and Yukio Yamashita and Hironori Shibata and Jun Ishihara and Tomonobu Hasegawa",

note = "Funding Information: Conflict of Interests: Tomonobu Hasegawa has the following financial relationships to disclose: Research funding from Novo Nordisk Pharma Ltd. and JCR Pharmaceuticals Co., Ltd.",

year = "2020",

doi = "10.1297/cpe.29.89",

language = "English",

volume = "29",

pages = "89--90",

journal = "clinical pediatric endocrinology",

issn = "0918-5739",

publisher = "Jeff Corporation Co. Ltd",

number = "2",

}

TY - JOUR

T1 - Central precocious puberty in a boy with pseudohypoparathyroidism type ia due to a novel GNAS mutation

AU - Kagami, Ryosuke

AU - Sato, Takeshi

AU - Ishii, Tomohiro

AU - Araki, Eriko

AU - Yamashita, Yukio

AU - Shibata, Hironori

AU - Ishihara, Jun

AU - Hasegawa, Tomonobu

N1 - Funding Information: Conflict of Interests: Tomonobu Hasegawa has the following financial relationships to disclose: Research funding from Novo Nordisk Pharma Ltd. and JCR Pharmaceuticals Co., Ltd.

PY - 2020

Y1 - 2020

UR - http://www.scopus.com/inward/record.url?scp=85083823887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85083823887&partnerID=8YFLogxK

U2 - 10.1297/cpe.29.89

DO - 10.1297/cpe.29.89

M3 - Article

AN - SCOPUS:85083823887

SN - 0918-5739

VL - 29

SP - 89

EP - 90

JO - clinical pediatric endocrinology

JF - clinical pediatric endocrinology

IS - 2

ER -

Central precocious puberty in a boy with pseudohypoparathyroidism type ia due to a novel GNAS mutation

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this